PEN Q2 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$299M+14.5% YoY

Gross Profit

$163M54.4% margin

Operating Income

-$81M-27.0% margin

Net Income

-$60M-20.1% margin

EPS (Diluted)

$-1.55

QoQ Revenue Growth

+7.4%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$18M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$373M

Stockholders' Equity

$1.2B

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$299M	$261M	+14.5%
Gross Profit	$163M	$167M	-2.4%
Operating Income	-$81M	$18M	-552.6%
Net Income	-$60M	$19M	-417.5%

Geographic Segments

UNITED STATES

$218M73%

Other Non-US

$81M27%